nodes	percent_of_prediction	percent_of_DWPC	metapath
Telavancin—Gastrointestinal ulcer haemorrhage—Fluorouracil—stomach cancer	0.0773	0.0773	CcSEcCtD
Telavancin—Abscess—Floxuridine—stomach cancer	0.0574	0.0574	CcSEcCtD
Telavancin—Necrosis—Mitomycin—stomach cancer	0.0454	0.0454	CcSEcCtD
Telavancin—Extravasation—Mitomycin—stomach cancer	0.0408	0.0408	CcSEcCtD
Telavancin—Gastrointestinal ulcer haemorrhage—Methotrexate—stomach cancer	0.0402	0.0402	CcSEcCtD
Telavancin—Ulcer—Mitomycin—stomach cancer	0.0377	0.0377	CcSEcCtD
Telavancin—Venous thrombosis—Capecitabine—stomach cancer	0.0192	0.0192	CcSEcCtD
Telavancin—Necrosis—Fluorouracil—stomach cancer	0.0189	0.0189	CcSEcCtD
Telavancin—Extravasation—Irinotecan—stomach cancer	0.0177	0.0177	CcSEcCtD
Telavancin—Tenderness—Fluorouracil—stomach cancer	0.017	0.017	CcSEcCtD
Telavancin—Extravasation—Fluorouracil—stomach cancer	0.017	0.017	CcSEcCtD
Telavancin—Ulcer—Irinotecan—stomach cancer	0.0164	0.0164	CcSEcCtD
Telavancin—Infection—Floxuridine—stomach cancer	0.0161	0.0161	CcSEcCtD
Telavancin—Ulcer—Fluorouracil—stomach cancer	0.0157	0.0157	CcSEcCtD
Telavancin—Necrosis—Docetaxel—stomach cancer	0.0136	0.0136	CcSEcCtD
Telavancin—Venous thrombosis—Epirubicin—stomach cancer	0.0134	0.0134	CcSEcCtD
Telavancin—Body temperature increased—Floxuridine—stomach cancer	0.0128	0.0128	CcSEcCtD
Telavancin—Venous thrombosis—Doxorubicin—stomach cancer	0.0124	0.0124	CcSEcCtD
Telavancin—Extravasation—Docetaxel—stomach cancer	0.0123	0.0123	CcSEcCtD
Telavancin—Hyponatraemia—Irinotecan—stomach cancer	0.0113	0.0113	CcSEcCtD
Telavancin—Gastrointestinal haemorrhage—Irinotecan—stomach cancer	0.0112	0.0112	CcSEcCtD
Telavancin—Diarrhoea—Floxuridine—stomach cancer	0.0111	0.0111	CcSEcCtD
Telavancin—Ulcer—Capecitabine—stomach cancer	0.0109	0.0109	CcSEcCtD
Telavancin—Gastrointestinal haemorrhage—Fluorouracil—stomach cancer	0.0108	0.0108	CcSEcCtD
Telavancin—Vomiting—Floxuridine—stomach cancer	0.0103	0.0103	CcSEcCtD
Telavancin—Rash—Floxuridine—stomach cancer	0.0102	0.0102	CcSEcCtD
Telavancin—Dermatitis—Floxuridine—stomach cancer	0.0102	0.0102	CcSEcCtD
Telavancin—Body temperature increased—Mitomycin—stomach cancer	0.01	0.01	CcSEcCtD
Telavancin—Necrosis—Methotrexate—stomach cancer	0.00982	0.00982	CcSEcCtD
Telavancin—Abscess—Methotrexate—stomach cancer	0.00974	0.00974	CcSEcCtD
Telavancin—Nausea—Floxuridine—stomach cancer	0.00962	0.00962	CcSEcCtD
Telavancin—Necrosis—Epirubicin—stomach cancer	0.00919	0.00919	CcSEcCtD
Telavancin—Abscess—Epirubicin—stomach cancer	0.00911	0.00911	CcSEcCtD
Telavancin—Phlebitis—Docetaxel—stomach cancer	0.00901	0.00901	CcSEcCtD
Telavancin—Extravasation—Methotrexate—stomach cancer	0.00883	0.00883	CcSEcCtD
Telavancin—Phlebitis—Capecitabine—stomach cancer	0.00872	0.00872	CcSEcCtD
Telavancin—Diarrhoea—Mitomycin—stomach cancer	0.00869	0.00869	CcSEcCtD
Telavancin—Necrosis—Doxorubicin—stomach cancer	0.0085	0.0085	CcSEcCtD
Telavancin—Abscess—Doxorubicin—stomach cancer	0.00843	0.00843	CcSEcCtD
Telavancin—Extravasation—Epirubicin—stomach cancer	0.00827	0.00827	CcSEcCtD
Telavancin—Ulcer—Methotrexate—stomach cancer	0.00815	0.00815	CcSEcCtD
Telavancin—Vomiting—Mitomycin—stomach cancer	0.00808	0.00808	CcSEcCtD
Telavancin—Rash—Mitomycin—stomach cancer	0.00801	0.00801	CcSEcCtD
Telavancin—Dermatitis—Mitomycin—stomach cancer	0.008	0.008	CcSEcCtD
Telavancin—Hyponatraemia—Docetaxel—stomach cancer	0.00779	0.00779	CcSEcCtD
Telavancin—Gastrointestinal haemorrhage—Docetaxel—stomach cancer	0.00776	0.00776	CcSEcCtD
Telavancin—Extravasation—Doxorubicin—stomach cancer	0.00765	0.00765	CcSEcCtD
Telavancin—Ulcer—Epirubicin—stomach cancer	0.00762	0.00762	CcSEcCtD
Telavancin—Nausea—Mitomycin—stomach cancer	0.00755	0.00755	CcSEcCtD
Telavancin—Hyponatraemia—Capecitabine—stomach cancer	0.00754	0.00754	CcSEcCtD
Telavancin—Gastrointestinal haemorrhage—Capecitabine—stomach cancer	0.00751	0.00751	CcSEcCtD
Telavancin—Hyperkalaemia—Epirubicin—stomach cancer	0.00708	0.00708	CcSEcCtD
Telavancin—Ulcer—Doxorubicin—stomach cancer	0.00705	0.00705	CcSEcCtD
Telavancin—Flatulence—Irinotecan—stomach cancer	0.00666	0.00666	CcSEcCtD
Telavancin—Hyperkalaemia—Doxorubicin—stomach cancer	0.00656	0.00656	CcSEcCtD
Telavancin—Abdominal discomfort—Capecitabine—stomach cancer	0.00623	0.00623	CcSEcCtD
Telavancin—Phlebitis—Epirubicin—stomach cancer	0.00608	0.00608	CcSEcCtD
Telavancin—Phlebitis—Doxorubicin—stomach cancer	0.00562	0.00562	CcSEcCtD
Telavancin—Infection—Irinotecan—stomach cancer	0.00548	0.00548	CcSEcCtD
Telavancin—Hyponatraemia—Epirubicin—stomach cancer	0.00526	0.00526	CcSEcCtD
Telavancin—Infection—Fluorouracil—stomach cancer	0.00525	0.00525	CcSEcCtD
Telavancin—Gastrointestinal haemorrhage—Epirubicin—stomach cancer	0.00523	0.00523	CcSEcCtD
Telavancin—Hyponatraemia—Doxorubicin—stomach cancer	0.00486	0.00486	CcSEcCtD
Telavancin—Gastrointestinal haemorrhage—Doxorubicin—stomach cancer	0.00484	0.00484	CcSEcCtD
Telavancin—Abdominal discomfort—Methotrexate—stomach cancer	0.00463	0.00463	CcSEcCtD
Telavancin—Flatulence—Capecitabine—stomach cancer	0.00446	0.00446	CcSEcCtD
Telavancin—Body temperature increased—Irinotecan—stomach cancer	0.00436	0.00436	CcSEcCtD
Telavancin—Body temperature increased—Fluorouracil—stomach cancer	0.00418	0.00418	CcSEcCtD
Telavancin—Infection—Docetaxel—stomach cancer	0.00379	0.00379	CcSEcCtD
Telavancin—Diarrhoea—Irinotecan—stomach cancer	0.00378	0.00378	CcSEcCtD
Telavancin—Infection—Capecitabine—stomach cancer	0.00367	0.00367	CcSEcCtD
Telavancin—Diarrhoea—Fluorouracil—stomach cancer	0.00362	0.00362	CcSEcCtD
Telavancin—Vomiting—Irinotecan—stomach cancer	0.00351	0.00351	CcSEcCtD
Telavancin—Rash—Irinotecan—stomach cancer	0.00348	0.00348	CcSEcCtD
Telavancin—Dermatitis—Irinotecan—stomach cancer	0.00348	0.00348	CcSEcCtD
Telavancin—Vomiting—Fluorouracil—stomach cancer	0.00336	0.00336	CcSEcCtD
Telavancin—Rash—Fluorouracil—stomach cancer	0.00333	0.00333	CcSEcCtD
Telavancin—Dermatitis—Fluorouracil—stomach cancer	0.00333	0.00333	CcSEcCtD
Telavancin—Nausea—Irinotecan—stomach cancer	0.00328	0.00328	CcSEcCtD
Telavancin—Nausea—Fluorouracil—stomach cancer	0.00314	0.00314	CcSEcCtD
Telavancin—Flatulence—Epirubicin—stomach cancer	0.00311	0.00311	CcSEcCtD
Telavancin—Body temperature increased—Docetaxel—stomach cancer	0.00302	0.00302	CcSEcCtD
Telavancin—Body temperature increased—Capecitabine—stomach cancer	0.00292	0.00292	CcSEcCtD
Telavancin—Flatulence—Doxorubicin—stomach cancer	0.00287	0.00287	CcSEcCtD
Telavancin—Infection—Methotrexate—stomach cancer	0.00273	0.00273	CcSEcCtD
Telavancin—Diarrhoea—Docetaxel—stomach cancer	0.00261	0.00261	CcSEcCtD
Telavancin—Infection—Epirubicin—stomach cancer	0.00256	0.00256	CcSEcCtD
Telavancin—Diarrhoea—Capecitabine—stomach cancer	0.00253	0.00253	CcSEcCtD
Telavancin—Vomiting—Docetaxel—stomach cancer	0.00243	0.00243	CcSEcCtD
Telavancin—Rash—Docetaxel—stomach cancer	0.0024	0.0024	CcSEcCtD
Telavancin—Dermatitis—Docetaxel—stomach cancer	0.0024	0.0024	CcSEcCtD
Telavancin—Infection—Doxorubicin—stomach cancer	0.00236	0.00236	CcSEcCtD
Telavancin—Vomiting—Capecitabine—stomach cancer	0.00235	0.00235	CcSEcCtD
Telavancin—Rash—Capecitabine—stomach cancer	0.00233	0.00233	CcSEcCtD
Telavancin—Dermatitis—Capecitabine—stomach cancer	0.00233	0.00233	CcSEcCtD
Telavancin—Nausea—Docetaxel—stomach cancer	0.00227	0.00227	CcSEcCtD
Telavancin—Nausea—Capecitabine—stomach cancer	0.00219	0.00219	CcSEcCtD
Telavancin—Body temperature increased—Methotrexate—stomach cancer	0.00217	0.00217	CcSEcCtD
Telavancin—Body temperature increased—Epirubicin—stomach cancer	0.00203	0.00203	CcSEcCtD
Telavancin—Body temperature increased—Doxorubicin—stomach cancer	0.00188	0.00188	CcSEcCtD
Telavancin—Diarrhoea—Methotrexate—stomach cancer	0.00188	0.00188	CcSEcCtD
Telavancin—Diarrhoea—Epirubicin—stomach cancer	0.00176	0.00176	CcSEcCtD
Telavancin—Vomiting—Methotrexate—stomach cancer	0.00175	0.00175	CcSEcCtD
Telavancin—Rash—Methotrexate—stomach cancer	0.00173	0.00173	CcSEcCtD
Telavancin—Dermatitis—Methotrexate—stomach cancer	0.00173	0.00173	CcSEcCtD
Telavancin—Vomiting—Epirubicin—stomach cancer	0.00164	0.00164	CcSEcCtD
Telavancin—Nausea—Methotrexate—stomach cancer	0.00163	0.00163	CcSEcCtD
Telavancin—Diarrhoea—Doxorubicin—stomach cancer	0.00163	0.00163	CcSEcCtD
Telavancin—Rash—Epirubicin—stomach cancer	0.00162	0.00162	CcSEcCtD
Telavancin—Dermatitis—Epirubicin—stomach cancer	0.00162	0.00162	CcSEcCtD
Telavancin—Nausea—Epirubicin—stomach cancer	0.00153	0.00153	CcSEcCtD
Telavancin—Vomiting—Doxorubicin—stomach cancer	0.00151	0.00151	CcSEcCtD
Telavancin—Rash—Doxorubicin—stomach cancer	0.0015	0.0015	CcSEcCtD
Telavancin—Dermatitis—Doxorubicin—stomach cancer	0.0015	0.0015	CcSEcCtD
Telavancin—Nausea—Doxorubicin—stomach cancer	0.00141	0.00141	CcSEcCtD
